Only 10% of the implants manufacturers can show scientific evidence about their products. Ticare supplies its users with a wide range of clinical studies performed with Ticare dental implants along the last 20 years.
Explains the topics of research in peri-implant health
Dr. Alberto Monje, a specialist in periodontology and implants, was interviewed by Maxillaris magazine in July during SEPA (Spanish Society of Periodontology) Congress in Seville, Spain. He explained the research currently carried out regarding the prevention of peri-implantitis and the progress that Ticare is doing in this regard. Full interview to Dr. Alberto Monje is available in this link.
Predicting is one of the keys to minimize the risk of peri-implant pathology
One of the clear axes that Ticare determined more than a decade ago is to anticipate the events that were coming. This is the case of this “tsunami” of peri-implantitis that we have currently been able to identify.
Predicting, one of the keys to minimizing the risk of peri-implant pathology
One of the main issues that Ticare determined more than a decade ago was to anticipate the events that were about to come.
Ticare participated at the congress organised by SECOM CyC (the Spanish Society of Oral and Maxillofacial Surgery and Head and Neck), that took place in Almeria, Spain.
At the exhibition, Ticare presented new products launched along the year as Ticare Perio Hybrid, the hybrid implant for the periodontal patient, and the TCP Prosthetic abutments together with the scientific studies carried out to certify them.